IP Library Granted Patent US 7,101,862
Granted Patent B2
US 7,101,862 · App. 10/334,864 · Granted Sep 5, 2006

Hemostatic compositions and methods for controlling bleeding

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,101,862
App. No.
10/334,864
Granted
Sep 5, 2006
Kind
B2
Abstract

The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g., cotton gauze, and a polysaccharide covalently linked to the cellulose, or a polysaccharide ionically cross-linked and in association with the article. Methods of making and using the hemostatic compositions are also provided.

Claims (14)

1. A bandage consisting essentially of a hemostatic composition, said hemostatic composition comprising cellulose and dextran covalently linked to said cellulose.

2. The bandage of claim 1 , wherein said dextran is in the form of covalently cross-linked beads.

3. The bandage of claim 1 , wherein the molecular weight of said dextran ranges from about 10,000 to about 2,000,000 Daltons.

4. The bandage of claim 3 , wherein the molecular weight of said dextran ranges from about 20,000 to about 100,000 Daltons.

5. The bandage of claim 1 , wherein said covalently linked dextran has a molecular weight exclusion limit greater than about 30,000 Daltons.

6. The bandage of claim 1 , wherein said cellulose is cotton.

7. The bandage of claim 6 , wherein said cellulose is cotton gauze.

8. The bandage of claim 1 , further comprising cross-linked alginate linked to said cellulose.

9. The bandage of claim 8 , wherein said cross-linked alginate is covalently linked to said cellulose.

10. The bandage of claim 8 , wherein said dextran is in the form of covalently cross-linked beads.

11. The bandage of claim 10 , wherein said covalently cross-linked dextran beads comprise Ca2+.

12. A bandage comprising a hemostatic composition, said hemostatic composition comprising ionically linked dextran-alginate spheres covalently linked to cellulose.

13. The bandage of claim 12 , wherein said ionically linked dextran-alginate spheres are linked ionically with Ca2+.

14. The bandage of claim 13 , wherein said ionically linked dextran-alginate spheres are further cross-linked covalently.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2012
From: THEIS, JEROLD, DR.
To: LIGHTY, CRAIG E.
Reel/Frame 028434/0986 →
LIEN Recorded Dec 9, 2009
From: CROSSLINK-D, INC.
To: FISH & RICHARDSON P.C.
Reel/Frame 023627/0209 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2009
From: CROSSLINK-D, INC.
To: INTERNATIONAL MANUFACTURING GROUP, INC.; THEIS, JEROLD
Reel/Frame 022813/0517 →
SECURITY AGREEMENT Recorded Jun 27, 2008
From: CROSSLINK-D, INC.
To: INTERNATIONAL MANUFACTURING GROUP, INC.
Reel/Frame 021165/0152 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2005
From: ARES LABORATORIES, LLC
To: CROSSLINK-D, INCORPORATED
Reel/Frame 017086/0031 →